Neutralization of IL‐17A using an anti‐IL‐17A mAb in aged mice significantly reduced the mean survival time from 45.10 to 38.20 days, demonstrating the critical anti‐tumor role of IL‐17A in the development of B16/F10 melanoma in aged lungs (Figure 5b). Here, IL17A is linked to melanoma.